{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:45:15Z","timestamp":1776120315580,"version":"3.50.1"},"reference-count":55,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[1998,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Recently, efficient and long-term in vivo gene transfer by recombinant adeno-associated virus type 2 (rAAV) vectors has been demonstrated in a variety of tissues. Further improvement in vector titer and purity will expedite this in vivo exploration and provide preclinical information required for use in human gene therapy. In an effort to obtain higher titers, we constructed a novel AAV helper plasmid which utilizes translational control of AAV Rep genes (J. Li et al., J. Virol. 71:5236\u20135243, 1997). To address the issue of purity, in this study we report the first rAAV production method which is completely free of adenovirus (Ad) helper virus. The new production system uses a plasmid construct which contains a mini-Ad genome capable of propagating rAAV in the presence of AAV Rep and Cap genes. This construct is missing some of the early and most of the late Ad genes and is incapable of producing infectious Ad. Transfection of 293 cells with the new mini-Ad helper and AAV packaging plasmids results in high-titer rAAV vectors with yields greater than 1,000 transducing units, or 10\n            <jats:sup>5<\/jats:sup>\n            viral particles per cell. When rAAV vectors were produced by using this production scheme and compared to traditional heat-inactivated rAAV preparations in vitro and in vivo, we observed transduction equivalent to or better than normal levels. The complete removal of infectious Ad from AAV production should facilitate a better understanding of immune response to AAV vectors in vivo, eliminate the need for developing replication-competent Ad assays, and provide a more defined reagent for clinical use.\n          <\/jats:p>","DOI":"10.1128\/jvi.72.3.2224-2232.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T18:09:07Z","timestamp":1577815747000},"page":"2224-2232","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1185,"title":["Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus"],"prefix":"10.1128","volume":"72","author":[{"given":"Xiao","family":"Xiao","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Gene Therapy Center,1"},{"name":"<!--label omitted: 2-->Division of Pharmaceutics,2 and"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Gene Therapy Center,1"}]},{"given":"Richard Jude","family":"Samulski","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Gene Therapy Center,1"},{"name":"<!--label omitted: 3-->Department of Pharmacology,3 University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.5.3235-3241.1996"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb44735.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.19.8802"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(89)90227-4"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1995.6.12-1531"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1997.8.6-659"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1995.6.10-1329"},{"key":"e_1_3_2_9_2","first-page":"1124","article-title":"A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors","volume":"3","author":"Clark K. R.","year":"1996","unstructured":"Clark K. R. Voulgaropoulou F. Johnson P. R. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.Gene Ther. 3 1996 1124 1132","journal-title":"Gene Ther."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.5.3227-3234.1996"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1197-1295"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.1.520-532.1996"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0397-306"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1996.7.17-2079"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.13.6916"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1996.7.9-1145"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.22.10613"},{"key":"e_1_3_2_18_2","first-page":"29","article-title":"An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction","volume":"2","author":"Flotte T. R.","year":"1995","unstructured":"Flotte T. R. Barraza-Ortiz X. Solow R. Afione S. A. Carter B. J. Guggino W. B. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction.Gene Ther. 2 1995 29 37","journal-title":"Gene Ther."},{"key":"e_1_3_2_19_2","first-page":"357","article-title":"Adeno-associated virus vectors for gene therapy","volume":"2","author":"Flotte T. R.","year":"1995","unstructured":"Flotte T. R. Carter B. J. Adeno-associated virus vectors for gene therapy.Gene Ther. 2 1995 357 362","journal-title":"Gene Ther."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.8.5239-5246.1994"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.81.20.6466"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.11.5804"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.1.317-324.1992"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1094-148"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.14082"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.4.1426"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1994.5.7-793"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.7.5236-5243.1997"},{"key":"e_1_3_2_29_2","unstructured":"Li J. et al. Unpublished data."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.6.2936-2945.1991"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(95)01488-8"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1995.6.12-1553"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.62.6.1963-1973.1988"},{"key":"e_1_3_2_34_2","unstructured":"Monahan P. E. J. Tazelaar X. Xiao T. C. Nicols D. A. Bellinger M. S. Read C. E. Walsh and R. J. Samulski. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. in press."},{"key":"e_1_3_2_35_2","unstructured":"Monahan P. E. et al. Unpublished data."},{"key":"e_1_3_2_36_2","first-page":"97","article-title":"Use of adeno-associated virus as a general transduction vector for mammalian cells","volume":"158","author":"Muzyczka N.","year":"1992","unstructured":"Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells.Curr. Top. Microbiol. Immunol. 158 1992 97 129","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_37_2","unstructured":"Muzyczka N. Personal communication."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300358"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.2.1079-1088.1997"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.6.4300-4309.1997"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.3.1747-1756.1997"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(96)00576-8"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.9.3822-3828.1989"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0797-270"},{"key":"e_1_3_2_45_2","first-page":"531","article-title":"Parvovirus-based vectors for human gene therapy","volume":"20","author":"Srivastava A.","year":"1994","unstructured":"Srivastava A. Parvovirus-based vectors for human gene therapy.Blood Cells 20 1994 531 536","journal-title":"Blood Cells"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1996.7.4-507"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.3.1897-1905.1997"},{"key":"e_1_3_2_48_2","unstructured":"Xiao X. Unpublished observations."},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1996.6396"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.11.8098-8108.1996"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00120-0"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.61.4.972-981.1987"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.4.2004-2015.1995"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.10.4407"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.14.12.8483-8492.1994"},{"key":"e_1_3_2_56_2","unstructured":"Zolotukhm S. Personal communication."}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.72.3.2224-2232.1998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.72.3.2224-2232.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:47:35Z","timestamp":1646448455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.72.3.2224-2232.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["10.1128\/JVI.72.3.2224-2232.1998"],"URL":"https:\/\/doi.org\/10.1128\/jvi.72.3.2224-2232.1998","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]},"assertion":[{"value":"1997-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-11-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}